Ross Bridget A 4

What Happened

• Bridget A. Ross, a director of Lemaitre Vascular, reported receipt of equity on Feb 26, 2026 tied to a Performance Share Unit (PSU) award. The filing shows 476 shares acquired as an award (476 shares @ $0.00, total $0).
• The filing also records two derivative conversions (code M): one conversion acquiring 1 share @ $0.00 and one conversion disposing 1 share @ $0.00. The net effect reported is an increase of 476 shares from the PSU settlement. This was an award/settlement event, not an open‑market purchase or sale.

Key Details

• Transaction date: February 26, 2026; Form 4 filed March 2, 2026 (timely filing).
• Reported amounts/prices: 476 shares (Award, A) at $0.00; 1 share acquired (M) at $0.00; 1 share disposed (M) at $0.00.
• Net change: +476 shares reported from PSU settlement.
• Shares owned after transaction: not disclosed in the excerpt provided.
• Relevant footnotes:
  • F1: 476 shares were issued upon settlement of a PSU granted Dec 6, 2024; 1/3 vested upon satisfaction of the performance condition on 2/26/2026, the balance vests in equal annual installments on the grant anniversary over the next two years.
  • F2/F3: The 1-share derivative entries reflect release of dividend equivalent rights tied to the PSU (each dividend equivalent equals one share).
• Transaction codes: A = award/grant; M = exercise/conversion of derivative.

Context

• PSUs are conditional awards that convert to actual shares when performance and/or time conditions are met; this filing reflects settlement of vested PSUs rather than a market trade.
• Dividend equivalent rights tied to the PSU were released and converted to shares on a one-for-one basis per the footnotes.
• Because this was an award settlement (reported at $0.00), the filing does not show cash paid by the insider and should not be interpreted as an open‑market purchase or sale.